Antidepressant combinations: Epidemiological considerations

Acta Psychiatrica Scandinavica, Supplement

Volumn 112, Issue 428, 2005, Pages 7-10

  Agüera, Luis F ^a,f   Rojo, J E ^b   Ros, S ^c   De La Gandara J ^d   De Pedro, J M ^e  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^e Organon Española S A   (Spain)

^f NONE   (Spain)

Author keywords

Antidepressants; Depression; Drug combinations; Epidemiology

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; FLUOXETINE; LITHIUM; NEUROLEPTIC AGENT; BENZODIAZEPINE DERIVATIVE; PSYCHOTROPIC AGENT;

CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; EPIDEMIOLOGICAL DATA; EVALUATION; HEALTH SURVEY; HUMAN; LITERATURE; MEDICAL RECORD; PRESCRIPTION; TREATMENT FAILURE; CLINICAL PRACTICE; CULTURAL FACTOR; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG RESISTANCE; DRUG UTILIZATION; METHODOLOGY; PHARMACOEPIDEMIOLOGY; PSYCHIATRY; PSYCHOLOGICAL ASPECT; REVIEW; STATISTICS;

ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; CROSS-CULTURAL COMPARISON; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; HUMANS; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRY; PSYCHOTROPIC DRUGS; RESEARCH DESIGN;

EID: 29044442132     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2005.00674.x     Document Type: Conference Paper

References (15)

1. TALEB M, GORWOOD P, BOULEAU JH, ROUILLON F. Tolérance et efficacité des associations d'antidépresseurs: revue de la littérature. Encéphale 1996;22:450-460.
2. THASE ME, HOWLAND RH, FRIEDMAN ES. Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry 1998;59:5-15.
3. CARPENTER L, ZELJKO J, HALL J, RASMUSSEN S, PRICE L. Mirtazapine augmentation in treatment of refractory depression. J Clin Psychiatry 1999;60:45-49.
4. FAVA M. New approaches to the treatment of refractory depression. J Clin Psychiatry 2000;61:26-32.
5. NELSON JC. Augmentation strategies in depression 2000. J Clin Psychiatry 2000;61:13-19.
6. DORDING CM. Antidepressant augmentation and combinations. Psychiatr Clin North Am 2000;23:743-755.
7. CORYELL W. Augmentation strategies for inadequate antidepressant response: a review of placebo-controlled studies. Ann Clin Psychiatry 2000;12:141-146.
8. NIERENBERG AA. Treatment choice after one antidepressant fails: a survey of northeaster psychiatrists. J Clin Psychiatry 1991;52:383-385.
9. FREEDMAN SJ, FAVA M, KIENKE AS, WHITE CN, NIERENBERG AA, ROSENBAUM JF. Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices. J Clin Psychiatry 2000;61:403-408.
10. BOUHASSIRA M, ALLICAR MP, BLACHIER C, NOUVEAU A, ROUILLON F. Which patients receive antidepressants? A 'real world' telephone study. J Affect Disord 1998;49:19-26.
11. DITTMANN RW, LINDEN M, OSTERHEIDER M, SCHAAF B, OHNMACHT U, WEBER HJ. Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine. Pharmacopsychiatry 1997;30:28-34.
12. OSHIMA A, HIGUCHI T, FUJIWARA Y et al. Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders. Psychiatry Clin Neurosci 1999;53(suppl.):S67-S72.
13. AGÜERA-ORTIZ LF, GONZÁLEZ PARRA S, SÁNCHEZ PIEDRA R, PALOMO T. Patrones de uso de los antiguos y nuevos antidepresivos en pacientes geriátricos con depresión. Actas Esp Psiquiatr 2000;28:343-352.
14. ROSHOLM JU, HALLAS J, GRAM LF. Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients - a prescription database study. Br J Clin Pharmacol 1994;37:533-538.
15. MCMANUS P, MANT A, MITCHELL P, BIRKETT D, DUDLEY J. Co-prescribing of SSRIs and tricyclic antidepressants in Australia: how often does it occur and who is doing it? Br J Clin Pharmacol 2001;51:93-98.